The takeover process has ended with German drugmaker Stada agreeing to be bought by investment groups Bain Capital and Cinven.
Bain Capital and Cinven increased the price to 5,3 billion Euro by uniting their offer and then convinced Stada administration to be sold.
It is expected that this partnership will enable them to invest more on health sector in the long-term.
Source: Euronews
Legal Notice: The information in this article is intended for information purposes only. It is not intended for professional information purposes specific to a person or an institution. Every institution has different requirements because of its own circumstances even though they bear a resemblance to each other. Consequently, it is your interest to consult on an expert before taking a decision based on information stated in this article and putting into practice. Neither MuhasebeNews nor related person or institutions are not responsible for any damages or losses that might occur in consequence of the use of the information in this article by private or formal, real or legal person and institutions.
